Massachusetts public company buys startup with ties to UMB
Published 5/1/20 in the Baltimore Business Journal A University of Maryland, Baltimore-born medical device startup that has been developing a kind of artificial lung was acquired by publicly traded health technology firm Abiomed. Abiomed (NASDAQ: ABMD) announced Thursday its acquisition …